Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails
This study has been completed.
Sponsor:
Chang Gung Memorial Hospital
Information provided by (Responsible Party):
Yin-ku Lin, Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00999687
First received: October 20, 2009
Last updated: January 3, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Results First Received: June 6, 2012
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Single Group Assignment; Masking: Single Blind (Outcomes Assessor); Primary Purpose: Treatment |
| Condition: |
Nail Psoriasis |
| Interventions: |
Drug: Indigo Naturalis Extract in Oil Other: Olive Oil |
Participant Flow
Recruitment Details
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| Participants recruited from ambulatory department of Chang Gung Memorial Hospital, in northern Taiwan between November 2009 and May 2011. |
Pre-Assignment Details
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| 35 participants recruited and screened, 4 excluded (3 did not meet the eligibility criteria and 1 refused participation). |
Reporting Groups
| Description | |
|---|---|
| All Participants (Indigo Naturalis Oil Extract /Olive Oil) | In all participants, indigo naturalis oil extract (INOE) was applied to the fingernails of one bilateral hand (experimental group) and olive oil was applied to the fingernails of the contralateral hand (control group) twice daily for 12 weeks. The randomization process was conducted by block randomization method with 1:1 ratio. After 12 weeks, olive oil treatment was discontinued and INOE was applied to both hands twice daily for another 12 weeks. |
Participant Flow for 2 periods
Period 1: First Intervention
| All Participants (Indigo Naturalis Oil Extract /Olive Oil) | |
|---|---|
| STARTED | 31 [1] |
| COMPLETED | 30 |
| NOT COMPLETED | 1 |
| Withdrawal by Subject | 1 |
| [1] | 16 used the INOE on the right hand,15 used the INOE on the left hand. |
|---|
Period 2: Second Intervention
| All Participants (Indigo Naturalis Oil Extract /Olive Oil) | |
|---|---|
| STARTED | 30 [1] |
| COMPLETED | 27 |
| NOT COMPLETED | 3 |
| Withdrawal by Subject | 2 |
| Lack of Efficacy | 1 |
| [1] | From week 13 to 24, all participants applied INOE to both hands twice daily. |
|---|
Baseline Characteristics
Reporting Groups
| Description | |
|---|---|
| All Participants (Indigo Naturalis Oil Extract /Olive Oil) | In all participants, indigo naturalis oil extract was applied to the fingernails of one bilateral hand (experimental group) and olive oil was applied to the fingernails of the contralateral hand (control group) twice daily for 12 weeks. The randomization process was conducted by block randomization method with 1:1 ratio. After 12 weeks, olive oil treatment was discontinued and indigo naturalis oil extract was applied to both hands twice daily for another 12 weeks. |
Baseline Measures
| All Participants (Indigo Naturalis Oil Extract /Olive Oil) | |
|---|---|
|
Number of Participants
[units: participants] |
31 |
|
Age
[units: years] Mean ± Standard Deviation |
40.7 ± 12.6 |
|
Gender
[units: participants] |
|
| Female | 7 |
| Male | 24 |
Outcome Measures
| 1. Primary: | Change From Baseline in Single-Hand Nail Psoriasis Severity Index (NAPSI)and in the Modified Target NAPSI for the Single Most Severely Affected Nail of Each Hand at Week 12. [ Time Frame: Baseline and Week 12 ] |
| 2. Primary: | Change From Baseline in Single-Hand Nail Psoriasis Severity Index (NAPSI)and in the Modified Target NAPSI for the Single Most Severely Affected Nail of Each Hand at Week 24. [ Time Frame: Baseline and Week 24 ] |
More Information
Certain Agreements:
Limitations and Caveats
Results Point of Contact:
No publications provided
| All Principal Investigators ARE employed by the organization sponsoring the study. |
Limitations and Caveats
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
Results Point of Contact:
Name/Title: Lin Yin-Ku MD.Ph.D.
Organization: Chang Gung Memorial Hospital
phone: 886-2-24313131 ext 2127
e-mail: lin1266@adm.cgmh.org.tw
Organization: Chang Gung Memorial Hospital
phone: 886-2-24313131 ext 2127
e-mail: lin1266@adm.cgmh.org.tw
No publications provided
| Responsible Party: | Yin-ku Lin, Chang Gung Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT00999687 History of Changes |
| Other Study ID Numbers: | CMRPG280191 |
| Study First Received: | October 20, 2009 |
| Results First Received: | June 6, 2012 |
| Last Updated: | January 3, 2013 |
| Health Authority: | Taiwan: Institutional Review Board |